385 related articles for article (PubMed ID: 9744770)
61. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
62. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
[TBL] [Abstract][Full Text] [Related]
63. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
[TBL] [Abstract][Full Text] [Related]
64. 6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia.
Welch JC; Lilleyman JS
Cancer Chemother Pharmacol; 1996; 38(1):113-6. PubMed ID: 8603445
[TBL] [Abstract][Full Text] [Related]
65. Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations.
Lennard L; Keen D; Lilleyman JS
Clin Pharmacol Ther; 1986 Sep; 40(3):287-92. PubMed ID: 3461899
[TBL] [Abstract][Full Text] [Related]
66. Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
Inamochi H; Higashigawa M; Shimono Y; Nagata T; Cao DC; Mao XY; M'soka T; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1999 Sep; 18(3):417-24. PubMed ID: 10606189
[TBL] [Abstract][Full Text] [Related]
67. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
68. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW
Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170
[TBL] [Abstract][Full Text] [Related]
69. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
[TBL] [Abstract][Full Text] [Related]
70. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
Lennard L; Welch JC; Lilleyman JS
Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
[TBL] [Abstract][Full Text] [Related]
71. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
Lennard L; Davies HA; Lilleyman JS
Br J Cancer; 1993 Jul; 68(1):186-90. PubMed ID: 8318412
[TBL] [Abstract][Full Text] [Related]
72. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.
Lilleyman JS; Lennard L
Lancet; 1994 May; 343(8907):1188-90. PubMed ID: 7909868
[TBL] [Abstract][Full Text] [Related]
73. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
[TBL] [Abstract][Full Text] [Related]
74. Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
Larsen RH; Hjalgrim LL; Grell K; Kristensen K; Pedersen LG; Brünner ED; Als-Nielsen B; Schmiegelow K; Nersting J
Cancer Chemother Pharmacol; 2020 Jul; 86(1):25-32. PubMed ID: 32519032
[TBL] [Abstract][Full Text] [Related]
75. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Kitchen BJ; Balis FM; Poplack DG; O'Brien M; Craig CE; Adamson PC
Clin Cancer Res; 1997 May; 3(5):713-7. PubMed ID: 9815740
[TBL] [Abstract][Full Text] [Related]
76. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
[TBL] [Abstract][Full Text] [Related]
77. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
78. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576
[TBL] [Abstract][Full Text] [Related]
79. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
80. High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood.
Erb N; Haverland U; Harms DO; Escherich G; Janka-Schaub G
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):87-94. PubMed ID: 14552819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
